Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
The state obesity drug coverage landscape will continue to evolve as states respond to the recent announcement of the BALANCE model (see Box 1) and as states contend with budget challenges and the federal Medicaid spending cuts in the 2025 reconciliation law
Target Audience: This article is written for physicians, clinical researchers, and allied healthcare professionals seeking an advanced understanding of the therapeutic potential and safety considerations of BPC-157 and TB-500
Frontiers in Bioengineering and Biotechnology , 10 , 852318
If you have a medical condition, taking medications or under the age of 18 consult your healthcare professional before using this product
US$ 20.01
US$ 25.11
US$ 26.09
US$ 29.89
US$ 28.12
US$ 29.45
